LSP-249 (example 35),信息来自专利WO2016011209A1,是血浆kallikrein 的抑制剂,用于血管性水肿的研究,EC50 值小于 100 nM。
货号:ajcx34242
CAS:1801253-04-2
分子式:C24H22ClN5O
分子量:431.92
溶解度:DMSO : 31.25 mg/mL (72.35 mM; ultrasonic and warming and heat to 60°C)
纯度:98%
存储:Store at -20°C
库存:
现货Background:
LSP-249 (example 35), extracted from patent WO2016011209A1, is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell[1].
[1]. Andrew Mcdonald, et al. Therapeutic inhibitory compounds. Patent. WO2016011209A1.